Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilnidipine in Hypertensive ADPKD Patients
NCT00541853Phase 4Unknown
- Sponsor
- Kyorin University
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cilnidipine in autosomal dominant polycystic kidney disease (ADPKD) and hypertension (HTN), sponsored by Kyorin University. Status: unknown.
02
Drugs
cilnidipine
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)hypertension (HTN)
Beyond the preview
Go deeper on NCT00541853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541853.